Platelet rich plasma for treatment of plantar fasciitis
Phase 2
- Conditions
- Plantar fasciitis.Plantar fascial fibromatosis
- Registration Number
- IRCT2015041821830N1
- Lead Sponsor
- Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
age of between 18 and 65 years; having chronic plantar fasciitis with duration of more than 3 months; no adequate response to conservative treatments
Exclusion criteria (not inclusion criteria): history of receiving corticosteroids within the last 6 weeks; history of surgical interventions in the ankle and the heel; receiving aspirin or NSAIDs within a week ago; history of stroke within the last three months; pregnancy or breast feeding; evidence of malignancy, anemia, diabetes, hypothyroidism, peripheral neuropathy, acute infection or fever, or coagulopathies
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: Before and 1 month, 3 months, and 6 months after treatment. Method of measurement: Visual Analogue Scale.
- Secondary Outcome Measures
Name Time Method Modified Roles and Maudsley score. Timepoint: Before and 1 month, 3 months, and 6 months after treatment. Method of measurement: Modified Roles and Maudsley Scale.;Plantar fascia thickness. Timepoint: Before and 3 months after treatment. Method of measurement: B-mode sonography.